iBio (IBIO) Change in Interest Receivables (2023 - 2026)
iBio's (IBIO) quarterly Change in Interest Receivables came in at $20000.0 in Q1 2026, up 42.86% year-on-year from $14000.0 in Q1 2025, and little changed on a QoQ basis from $20000.0 in Q4 2025.
iBio (IBIO) Change in Interest Receivables (2023 - 2026) Analysis & Trends
iBio (IBIO) has 4 years of Change in Interest Receivables data on file, last reported at $20000.0 in Q1 2026.
- On a quarterly basis, Change in Interest Receivables rose 42.86% year-over-year to $20000.0 in Q1 2026; TTM through Mar 2026 was $74000.0, a 7.25% increase from a year earlier, with the FY2025 full-year figure at $62000.0, down 29.55% from the prior year.
- Change in Interest Receivables for Q1 2026 stood at $20000.0, roughly flat from $20000.0 in the prior quarter.
- Over the last five years, Change in Interest Receivables for IBIO reached as high as $22000.0 in Q3 2023 and fell as low as $14000.0 in Q4 2024.
- Historically, Change in Interest Receivables has averaged $19000.0 across 4 years, with a median of $20000.0 in 2025.
- Across the five-year window, Change in Interest Receivables sank 36.36% in 2024 and jumped 42.86% in 2025, its largest moves.
- Year by year, Change in Interest Receivables stood at $22000.0 in 2023, then sank by 36.36% to $14000.0 in 2024, then soared by 42.86% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- Per Business Quant data, the three most recent Change in Interest Receivables figures were $20000.0 in Q1 2026, $20000.0 in Q4 2025, and $19000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 22,000.00 |